Side-by-side comparison of AI visibility scores, market position, and capabilities
Cleveland OH Midwest/Mountain West regional bank (NYSE: KEY) ~$7.8B FY2024 revenue; Scotiabank $2.8B equity investment 2024, KBCM middle market investment banking, competing with Huntington and Fifth Third.
KeyCorp is a Cleveland, Ohio-based regional bank holding company — publicly traded on the New York Stock Exchange (NYSE: KEY) as an S&P 500 Financials component — providing commercial and retail banking, investment banking, wealth management, and capital markets services through KeyBank National Association across a 15-state footprint primarily in the Midwest, Mountain West, Pacific Northwest, and Alaska through approximately 17,000 employees. In fiscal year 2024, KeyCorp reported net revenues of approximately $7.8 billion, with the company executing a significant strategic capital action: in August 2024, Bank of Nova Scotia (Scotiabank) agreed to invest $2.8 billion in KeyCorp through a 14.9% equity stake acquisition — providing KeyCorp with common equity Tier 1 capital to support balance sheet repositioning (selling low-yielding bond securities purchased in 2020-2021 at low rates, reinvesting at higher rates to improve net interest income trajectory) and to fund commercial banking growth. CEO Chris Gorman's strategy of repositioning KeyCorp from a diversified financial services company toward a "relationship bank" model emphasizes middle market commercial lending (companies with $25M-$2B in revenue), commercial mortgage banking, and KeyBanc Capital Markets investment banking as the differentiated businesses where KeyCorp generates above-average revenue per relationship compared to consumer banking. KeyCorp's investment banking arm (KeyBanc Capital Markets — KBCM) provides middle market companies with equity capital markets (ECM — IPOs, follow-on offerings, convertibles), debt capital markets (DCM — leveraged loans, high-yield bonds), and M&A advisory capabilities that regional bank-scaled investment banks rarely match.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.